These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31685737)

  • 1. [Lysophosphatidic Acid Receptor Signaling Underlying Chronic Pain and Neuroprotective Mechanisms through Prothymosin α].
    Ueda H
    Yakugaku Zasshi; 2019; 139(11):1403-1415. PubMed ID: 31685737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prothymosinα, as a neuroprotective DAMPs/Alarmins molecule].
    Ueda H; Maeda S
    Nihon Yakurigaku Zasshi; 2018; 151(1):15-19. PubMed ID: 29321391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice.
    Sasaki K; Halder SK; Matsunaga H; Ueda H
    Peptides; 2020 Apr; 126():170265. PubMed ID: 31982448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecto-F
    Ueda H; Matsunaga H; Matsushita Y; Maeda S; Iwamoto R; Yokoyama S; Shirouzu M
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):89-94. PubMed ID: 30063859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evidence for the involvement of F
    Halder SK; Matsunaga H; Ueda H
    J Pharmacol Sci; 2020 Jun; 143(2):127-131. PubMed ID: 32156464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion.
    Ueda H; Halder SK; Matsunaga H; Sasaki K; Maeda S
    Neuroscience; 2016 Mar; 318():206-18. PubMed ID: 26779836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.
    Halder SK; Matsunaga H; Ishii KJ; Ueda H
    J Neurochem; 2015 Dec; 135(6):1161-77. PubMed ID: 26364961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.
    Matsunaga H; Halder SK; Ueda H
    Cell Mol Neurobiol; 2021 Nov; 41(8):1817-1828. PubMed ID: 32856232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia.
    Ueda H
    Pain Manag; 2020 Jan; 10(1):43-53. PubMed ID: 31852400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke.
    Ueda H
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):315-23. PubMed ID: 18176798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages.
    Maeda S; Sasaki K; Halder SK; Fujita W; Ueda H
    J Pharmacol Sci; 2016 Sep; 132(1):100-104. PubMed ID: 27543170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Pathology of Neuropathic Pain and Fibromyalgia.
    Ueda H
    Biol Pharm Bull; 2019; 42(11):1773-1782. PubMed ID: 31685762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist.
    Ma L; Matsumoto M; Xie W; Inoue M; Ueda H
    J Neurochem; 2009 Apr; 109(2):603-10. PubMed ID: 19222705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.
    Ueda H
    Pharmacol Ther; 2009 Sep; 123(3):323-33. PubMed ID: 19500618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
    Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
    PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.
    Karapetian RN; Evstafieva AG; Abaeva IS; Chichkova NV; Filonov GS; Rubtsov YP; Sukhacheva EA; Melnikov SV; Schneider U; Wanker EE; Vartapetian AB
    Mol Cell Biol; 2005 Feb; 25(3):1089-99. PubMed ID: 15657435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothymosin alpha in vivo contains phosphorylated glutamic acid residues.
    Trumbore MW; Wang RH; Enkemann SA; Berger SL
    J Biol Chem; 1997 Oct; 272(42):26394-404. PubMed ID: 9334214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Nuclear Localizing Signal Attenuates Proinflammatory Activity of Prothymosin-Alpha and Enhances Its Neuroprotective Effect on Transient Ischemic Stroke.
    Wang LC; Wu CL; Cheng YY; Tsai KJ
    Mol Neurobiol; 2017 Jan; 54(1):582-593. PubMed ID: 26746667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear targeting of prothymosin alpha.
    Manrow RE; Sburlati AR; Hanover JA; Berger SL
    J Biol Chem; 1991 Feb; 266(6):3916-24. PubMed ID: 1899869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple tRNA attachment sites in prothymosin alpha.
    Lukashev DE; Chichkova NV; Vartapetian AB
    FEBS Lett; 1999 May; 451(2):118-24. PubMed ID: 10371150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.